Sun.Oct 02, 2022

article thumbnail

Who is the best DTC provider and payer for telehealth?

MedCity News

The key reasons for patient satisfaction with telehealth was having adequate facetime, the report said. Those who were ranked high spent enough time providing quality care, explained health concepts clearly and completely resolved medical issues on the first visit.

Medical 93
article thumbnail

Advancing Global Collaboration for Drug Testing, Regulation, and Manufacturing

PharmaTech

FDA backs joint reviews, common research policies, and modern production methods around the world.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Careviso rakes in $17M to enhance price transparency in diagnostic testing

MedCity News

Virginia-based Careviso recently raised $17 million in Series B funds. The company — which is focused on improving transparency and access for diagnostic testing — will use the funds to enhance its platform’s price transparency tool and deploy it in physician offices so it can be used at the point of care.

article thumbnail

Next-Generation Synthetic Biology Workflow Platform

PharmaTech

Codex DNA’s BioXp 9600 system is designed for the automated synthesis of synthetic biology workflows.

93
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

BMS was first but startup Sudo Bio aims to be best at blocking key autoimmune target

MedCity News

Sudo Bioscience emerged with $37 million in funding and four programs that address TYK2, a promising target for autoimmune diseases. Bristol Myers Squibb drug Sotyktu recently won the first FDA approval for a TYK2 inhibitor but Sudo claims its molecules have the potential to be best in this new drug class.

FDA 89
article thumbnail

Securing Europe’s Critical Entities from Cyber Attacks

PharmaTech

Under the revised NIS-2 Directive in Europe, pharma companies will need to be proactive in safeguarding their digital assets.

Pharma 97

More Trending

article thumbnail

Regulatory Compliance Versus Real Compliance

PharmaTech

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, addresses the difference between regulatory compliance and real compliance.

52
article thumbnail

Expert: ‘We All Hold Implicit Biases’ That May Contradict Explicit Beliefs, Impact Patient Health

Pharmacy Times

As individuals in a society, all people have implicit, or unconscious, beliefs that they have been socialized to hold; however, health care professionals’ implicit biases can impact patients’ lives.

article thumbnail

Continuous Granulator with Integrated Dryer

PharmaTech

L.B. Bohle’s QbCon 1 is intended to meet all quality requirements for long granulation processing time.

52
article thumbnail

Inorganic DNA Replication Enzyme

PharmaTech

The new inorganic pyrophosphate from Canvax is intended for use in RNA IVT reactions.

52
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Optimizing Quality

PharmaTech

The 1VQ papers advocate for the idea that certain post-approval changes should be streamlined and expedited.

40
article thumbnail

Ergonomic, Safety-Focused Blenders

PharmaTech

ROSS Ribbon Blenders are a customizable solution designed to minimize risk and maximize productivity.

Safety 40
article thumbnail

Industry’s Best Secret

PharmaTech

One can only learn the secrets of "fight club" by attending its meetings.

52